Impax to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

May 4, 2016

HAYWARD, Calif., May 4, 2016 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016 at 9:20 a.m. Pacific Time. The conference will be held in Las Vegas, NV.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com.  This presentation will be archived on the Company's web site for 90 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Impax Generics division and markets its branded products through the Impax Specialty Pharma division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams, and ointments. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Company Contacts:                                                
Mark Donohue 
Investor Relations and Corporate Communications   
(215) 558-4526                                                        
www.impaxlabs.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/impax-to-present-at-the-bank-of-america-merrill-lynch-2016-health-care-conference-300262646.html

SOURCE Impax Laboratories, Inc.